H.I.G. Capital News
-
DENVER – June 9, 2022 – Today Leiters has announced that Memorial Hermann Health System – a non-profit, community-focused, award-winning health system committed to creating healthier Houston communities – has joined the company’s growing list of strategic health system investor…
-
BRIDGEWATER, NJ – April 28, 2022 – Nevakar Injectables Inc. (“Nevakar”), a wholly owned subsidiary of Nevakar, Inc., is a biopharmaceutical company developing multiple sterile injectable products for use in the critical and ambulatory care settings, and announced today that…
-
April 15, 2022 - Click Therapeutics Closes $15 Million Debt Financing from Silicon Valley Bank
NEW YORK – April 15, 2022 – Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that it has secured a $15 million term loan from Silicon Valley Bank. Proceeds from the financing were used in part to retire…
-
PARIS & BOSTON – March 8, 2022 – On Target Laboratories, Inc. (‘On Target’) a privately-held biotechnology company developing intraoperative molecular imaging agents to target and illuminate cancer during surgery and Mauna Kea Technologies (Paris:MKEA) (OTCQX:MKEAY)…
-
March 2, 2022 - H.I.G. Capital Expands BioHealth Team with Addition of Gwen Watanabe
STAMFORD – March 2, 2022 – H.I.G. Capital (“H.I.G.”), a leading global alternative investment firm with over $47 billion of equity capital under management, is pleased to announce that Gwen Watanabe has joined the firm’s dedicated life-science investment affiliate, H.I.G.…
-
DENVER – February 8, 2022 – Leiters, a trusted FDA-registered 503B outsourcing provider of hospital and ophthalmology compounded sterile preparations announced today that it has completed the purchase of a new manufacturing facility in Buena, New Jersey. The 110,000 square foot…
-
CHICAGO – January 18, 2022 – Augmedics, a pioneer in augmented reality (AR) surgical navigation, today announced its newest executive leadership addition in support of the accelerating growth of the company’s revolutionary AR-driven xvision system®. The company announced the…
-
December 14, 2021 - Zerigo Health Expands Board of Directors
SAN DIEGO – December 14, 2021 – Zerigo Health, which delivers the only connected light therapy solution for treating chronic skin conditions at home or on the go, today announced the appointments of Joseph E. Giles and Christina LaMontagne to the company’s Board of Directors.…
-
December 9, 2021 - Zerigo Health Appoints Helen Calvin as President and Chief Commercial Officer
SAN DIEGO – December 9, 2021 – Zerigo Health, which delivers the only connected light therapy solution for treating chronic skin conditions at home or on the go, today announced the appointment of Helen Calvin as President and Chief Commercial Officer. She will lead Zerigo’s growing…
-
WEST LAFAYETTE, INDIANA - November 29, 2021 - On Target Laboratories, Inc., a privately-held biotechnology company developing fluorescent imaging agents to target and illuminate cancer during surgery, today announced that the U.S. Food and Drug Administration (FDA) has approved CYTALUX…
-
November 18, 2021 - BIOVECTRA mRNA Vaccine and Bio-manufacturing Facility Announced
CHARLOTTETOWN, PRINCE EDWARD ISLAND - November 18, 2021 - BIOVECTRA today announced plans for the development of a state-of-the-art facility specializing in the production and manufacturing of mRNA vaccines and therapeutics – one of the first of its kind in Canada. This exciting new…
-
DENVER & NEW YORK – November 9, 2021 – Welsh, Carson, Anderson & Stowe (WCAS), a leading private equity firm focused exclusively on the healthcare and technology industries, announced today it has acquired a majority ownership stake in Leiters, a rapidly growing leader in…
-
October 26, 2021 - H.I.G. BioHealth Partners Co-Leads a $52M Financing for Click Therapeutics
STAMFORD, CT – October 26, 2021 - H.I.G. BioHealth Partners (“H.I.G.”), the dedicated healthcare investment affiliate of H.I.G. Capital, a leading global alternative investment firm with over $45 billion of equity capital under management,* is pleased to announce that it has co-led…
-
SAN DIEGO – October 21, 2021 – Zerigo Health, which delivers the only connected light therapy solution for treating chronic skin conditions at home or on the go, today announced a $43 million Series B investment led by 7wireVentures, joined by General Catalyst, Dragoneer, Cigna…
-
CHARLOTTETOWN, PRINCE EDWARD ISLAND – October 21, 2021 – BIOVECTRA, a leading Canadian biotech and pharmaceutical CDMO has appointed Gordon C. McCauley, President and CEO of adMare BioInnovations and Steven Klosk CEO (retired) Cambrex Corporation, to its board of directors. “Mr.…
-
NORTHBROOK, IL AND GREENWICH, CT - September 16, 2021 - Clarus Therapeutics Holdings, Inc. (“Clarus”) (Nasdaq:CRXT), a pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women, and McGill University…
-
NORTHBROOK, IL and GREENWICH, CT - September 9, 2021 - Clarus Therapeutics, Inc., a specialty pharmaceutical company dedicated to providing solutions to unmet medical needs by advancing androgen and metabolic therapies for men and women (“Clarus”), and Blue Water Acquisition Corp.…